BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
6.13
-0.27 (-4.22%)
Feb 13, 2026, 4:00 PM EST - Market closed
BiomX Market Cap
BiomX has a market cap or net worth of $9.77 million as of February 13, 2026. Its market cap has decreased by -23.85% in one year.
Market Cap
9.77M
Enterprise Value
9.43M
1-Year Change
-23.85%
Ranking
Category
Stock Price
$6.13
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $9.77M, a decrease of -99.49%. That is a compound annual growth rate of -55.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.77M | 242.17% |
| Dec 31, 2025 | 2.85M | -78.49% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 11.05M |
| KALA BIO | 10.98M |
| Bolt Biotherapeutics | 10.01M |
| CalciMedica | 9.94M |
| GridAI Technologies | 9.75M |
| CollPlant Biotechnologies | 9.65M |
| Chemomab Therapeutics | 9.29M |
| Pulmatrix | 8.98M |